Release – Ocugen Provides Business Update & Second Quarter 2022 Financial Results



Ocugen Provides Business Update & Second Quarter 2022 Financial Results

Research, News, and Market Data on Ocugen

CONFERENCE CALL AND WEBCAST TODAY AT 8:30 A.M. ET

 

  • Dosing
    patients in U.S. Phase 2/3 COVAXIN™ (BBV152) clinical trial
  • Completed
    dosing of patients in Cohort 1 of OCU400 gene therapy product candidate
  • Expanding
    product pipeline with the regenerative medicine cell therapy program
    NeoCart
    ®

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today reported financial results for the quarter ended June 30, 2022, and provided a general business update.

“The second quarter was marked by several important milestones,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “On the vaccine front, we continued to work diligently with our co-development partner, Bharat Biotech, to ensure we execute our planned clinical and commercial objectives for COVAXIN™ – a whole-virion inactivated COVID-19 vaccine candidate.”

“We are also excited and encouraged by the positive momentum of our investigational modifier gene therapy platform, with the potential to address many different gene mutations in the retina and look forward to bringing hope to patients for whom no treatment options exist,” Dr. Musunuri added.

During the second quarter, Ocugen expanded its dynamic clinical product pipeline with the introduction of NeoCart®, an innovative Phase 3-ready cell therapy platform. The U.S. Food and Drug Administration (FDA) recently granted NeoCart® a Regenerative Medicine Advanced Therapy (RMAT) designation for the repair of full-thickness lesions of the knee cartilage in adults, and this candidate, if approved, offers the potential for a new therapeutic option in this area.

“With our diversified portfolio, Ocugen is well-positioned to advance our product development efforts and we look forward to sharing key data as these programs progress,” Dr. Musunuri concluded.

Clinical and Business
Updates

Vaccines

  • COVAXIN™ Development in the
    United States
     – The Phase 2/3 immuno-bridging and broadening clinical trial, OCU-002, for COVAXIN™ is progressing well.
    • The Company is actively engaged in planning for the initiation of an adult safety clinical trial this year.
  • COVAXIN™ Data Published in
    Scientific Journals
     – In June 2022, positive pediatric Phase 2/3 study results in children aged 2-18 years were published in The Lancet Infectious Diseases. A study published in Nature
    Scientific Reports
     in July shows that COVAXIN™ (BBV152) generated a persistent cell mediated memory immune response for up to 12 months. Additionally, a booster dose is safe and ensures persistent immunity to minimize breakthrough infections of COVID-19.

Gene Therapies

  • OCU400 Clinical Trial – Dosing of subjects with retinitis pigmentosa in Cohort 1 was completed. Previously, the Company reported “first patient, first dose” in late March 2022.
    • The Independent Data and Safety Monitoring Board (DSMB) for the clinical trial recently completed a review of safety data based on dosing from Cohort 1 and recommends proceeding to dosing in Cohort 2. The Company expects to begin dosing in Cohort 2 this month.
  • OCU410 Development Program – Ocugen is conducting IND-enabling studies as per discussions with the FDA. A clinical trial is scheduled to begin next year, and the Company is currently manufacturing materials to support the clinical trial.
  • Improved Patent Estate – In June 2022, the Company announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,351,225, which is directed to methods for preventing or treating an ocular disease or disorder associated with retinal degenerative disease. The patent covers the use of a nuclear hormone receptor gene, such as nuclear receptor subfamily 2 group E member 3 (NR2E3), RAR-related orphan receptor A (RORA), Nuclear Protein 1, Transcriptional Regulator (NUPR1), and Nuclear Receptor Subfamily 2 Group C Member 1 (NR2C1), in treating retinal degenerative diseases as well as reducing the risk of developing such diseases.

Cell Therapies

  • Expansion of Product Candidate
    Pipeline with NeoCart
    ® – Ocugen added NeoCart®, a Phase 3-ready cell therapy platform technology to its diverse product candidate pipeline. The Company originally acquired NeoCart® as part of the Company’s reverse merger with Histogenics Corporation in 2019. Ocugen is currently working with the FDA to finalize the Phase 3 protocol necessary to advance the clinical development program of NeoCart®. Also, the Company entered into a collaborative research agreement with Brigham and Women’s Hospital, Harvard Medical School, to support NeoCart® development and explore expansion of the pipeline.

Other Business

  • At-the-Market Stock Issuance – In June 2022, the Company announced it had entered into an At Market Issuance Sales Agreement relating to the sale of shares of Ocugen’s common stock having an aggregate gross sales price of up to $160.0 million. Proceeds will be used for general corporate purposes.
  • Community Recognition – In June 2022, the Philadelphia Business
    Journal
     named Ocugen among the region’s “2022 Best Places to Work.”

Second Quarter 2022
Financial Results

  • The Company’s cash, cash equivalents, and restricted cash totaled $115.0 million as of June 30, 2022, compared to $95.1 million as of December 31, 2021. The Company believes that its current cash and cash equivalents balance will enable it to fund its operations into the second quarter of 2023. The Company had 216.1 million shares of common stock outstanding as of June 30, 2022.
  • Research and development expenses for the three months ended June 30, 2022, were $9.0 million compared to $18.9 million for the three months ended June 30, 2021. Research and development expenses for the three months ended June 30, 2021, included a $15.0 million upfront payment to Bharat Biotech for the right and license to COVAXIN™ development, manufacturing, and commercialization in Canada.  
  • General and administrative expenses for the three months ended June 30, 2022, were $10.6 million compared to $6.8 million for the three months ended June 30, 2021.
  • Ocugen reported a $0.09 net loss per share for the three months ended June 30, 2022, compared to a $0.13 net loss per share for the three months ended June 30, 2021.

Conference Call and
Webcast Details

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive management team will host the call, which will be open to all listeners. There will also be a question-and-answer session following the prepared remarks.

Attendees are invited to participate on the call using the following details:

Dial-in Numbers: (800) 715-9871 for U.S. callers and (646) 307-1963 for international callers
Conference ID: 7036957
Webcast: Available on the events section of the Ocugen investor site

A replay of the call and archived webcast will be available for approximately 45 days following the event on the Ocugen investor site.

About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. 

Discover more at www.ocugen.com and follow us on Twitter and LinkedIn.

Cautionary Note on
Forward-Looking Statements

This press release contains forward-looking statements within the meaning of
The Private Securities Litigation Reform Act of 1995, which are subject to
risks and uncertainties. We may, in some cases, use terms such as “predicts,”
“believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,”
“expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or
other words that convey uncertainty of future events or outcomes to identify
these forward-looking statements. Such forward-looking statements include, but
are not limited to, statements about the potential for NeoCart
® (autologous chondrocyte-derived neocartilage), if
approved, to provide an innovative new option for the repair of full-thickness
lesions of the knee cartilage in adults, as well as Ocugen’s intention to begin
dosing in Cohort 2 of the OCU400 clinical trial this month. Such statements are
subject to numerous important factors, risks, and uncertainties that may cause
actual events or results to differ materially from our current expectations.
These and other risks and uncertainties are more fully described in our
periodic filings with the Securities and Exchange Commission (SEC), including
the risk factors described in the section entitled “Risk Factors” in the
quarterly and annual reports that we file with the SEC. Any forward-looking
statements that we make in this press release speak only as of the date of this
press release. Except as required by law, we assume no obligation to update
forward-looking statements contained in this press release whether as a result
of new information, future events, or otherwise, after the date of this press
release.

Contact:

Tiffany Hamilton
Head of Communications
IR@ocugen.com

(Tables to follow)

OCUGEN, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

 

June 30, 2022

 

December 31, 2021

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

115,005

 

 

$

94,958

 

Prepaid expenses and other current assets

 

7,564

 

 

 

7,688

 

Total current assets

 

122,569

 

 

 

102,646

 

Property and equipment, net

 

3,153

 

 

 

1,164

 

Restricted cash

 

 

 

 

151

 

Other assets

 

4,366

 

 

 

1,800

 

Total assets

$

130,088

 

 

$

105,761

 

Liabilities and stockholders’ equity

 

 

 

Current liabilities

 

 

 

Accounts payable

$

5,921

 

 

$

2,312

 

Accrued expenses

 

4,103

 

 

 

4,325

 

Operating lease obligations

 

314

 

 

 

363

 

Total current liabilities

 

10,338

 

 

 

7,000

 

Non-current liabilities

 

 

 

Operating lease obligations, less current portion

 

3,892

 

 

 

1,231

 

Long term debt, net

 

1,750

 

 

 

1,712

 

Total liabilities

 

15,980

 

 

 

9,943

 

Stockholders’ equity

 

 

 

Convertible preferred stock

 

1

 

 

 

1

 

Common stock

 

2,163

 

 

 

1,995

 

Treasury stock

 

(48

)

 

 

(48

)

Additional paid-in capital

 

281,139

 

 

 

225,537

 

Accumulated other comprehensive income

 

10

 

 

 

 

Accumulated deficit

 

(169,157

)

 

 

(131,667

)

Total stockholders’ equity

 

114,108

 

 

 

95,818

 

Total liabilities and stockholders’ equity

$

130,088

 

 

$

105,761

 

 

OCUGEN, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Operating expenses

 

 

 

 

 

 

 

Research and development

$

9,007

 

 

$

18,853

 

 

$

16,922

 

 

$

21,725

 

General and administrative

 

10,558

 

 

 

6,757

 

 

 

20,677

 

 

 

10,942

 

Total operating expenses

 

19,565

 

 

 

25,610

 

 

 

37,599

 

 

 

32,667

 

Loss from operations

 

(19,565

)

 

 

(25,610

)

 

 

(37,599

)

 

 

(32,667

)

Other income (expense), net

 

94

 

 

 

(342

)

 

 

109

 

 

 

(362

)

Net loss

$

(19,471

)

 

$

(25,952

)

 

$

(37,490

)

 

$

(33,029

)

Shares used in calculating net loss per common share — basic and diluted

 

215,862,977

 

 

 

195,572,189

 

 

 

210,806,330

 

 

 

190,960,775

 

Net loss per share of common stock — basic and diluted

$

(0.09

)

 

$

(0.13

)

 

$

(0.18

)

 

$

(0.17

)

 


Alvopetro Energy (ALVOF) – Company update shows execution of game plan

Friday, August 05, 2022

Alvopetro Energy (ALVOF)
Company update shows execution of game plan

Alvopetro Energy Ltd.’s vision is to become a leading independent upstream and midstream operator in Brazil. Our strategy is to unlock the on-shore natural gas potential in the state of Bahia in Brazil, building off the development of our Caburé natural gas field and our strategic midstream infrastructure.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Management reported an update on production, drilling, and price adjustments. July sales volume averaged 2,514 boe/d. This is an increase over June sales of 2,480 and May sales of 2,111 (includes 5 day processing plant shutdown). June-quarter volumes were up 7% year over year. Production for the month of June equates to roughly 15 mmcf/d gas equivalent. Production is expected to increase beginning in August with the Cabure gas processing facility expanding to 18 mmcf/d capacity. 

Additional statistical interval data on recently-drilled wells looks favorable. The 183-B1 and 182-C1 wells both discovered potential net natural gas pay in multiple formations. Both wells are subject to testing. Both wells lie west of existing production in the Murucututu/Gomo project. The new field could be a critical component of Alvopetro’s long-term growth plans. On the Mururcututu project, the company is close to bringing a new well (183-1) to production and is extending pipeline to tie in another well (197-1) in the fourth quarter. New wells will help expand total production to the processing plant’s new capacity of 18 mmcf/d….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Avivagen Inc. (VIVXF) – AB Vista Gets on the Board

Friday, August 05, 2022

Avivagen Inc. (VIVXF)
AB Vista Gets on the Board

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A Pathway Into Brazil. Avivagen’s management announced Wednesday that the Company has received a 1.2 tonne order of OxC-beta from AB Vista that will be shipped for use in Brazil. It will be used for ongoing trials with several large poultry and cattle producers. We believe that this is a stepping stone in Avivagen’s aggressive marketing in OxC-beta, as the order represents increased awareness of the product.

Brazil Market. As a reminder, AB Vista is the exclusive distribution partner for Avivagen in the United States, Brazil, and Thailand. Brazil is the third largest for animal feed behind China and the U.S., and produced 80.1mmt in 2021. We anticipate more deals coming from the Brazil market, as AB Vista has existing relationships and distribution partnerships it can use to further sales of the OxC-beta product….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CoreCivic, Inc. (CXW) – Post Call Commentary and Updated Projections

Friday, August 05, 2022

CoreCivic, Inc. (CXW)
Post Call Commentary and Updated Projections

CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that serve the public good through high-quality corrections and detention management, a network of residential and non-residential alternatives to incarceration to help address America’s recidivism crisis, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and believe we are the largest private owner of real estate used by government agencies in the United States. We have been a flexible and dependable partner for government for nearly 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Behind the Miss. There were a number of items with the most significant being the La Palma transition, both the cost of implementing the transition as well as a faster drawn down of the existing ICE population than was anticipated, a challenging labor market where CoreCivic has implemented above average wage increases, and the impact of contract non-renewals and asset dispositions.

Upside Potential Remains. Due to the COVID regulations, CoreCivic’s occupancy levels remain well below historical norms. A return to pre-COVID occupancy levels, or about an additional 8,000 detainees, could add some $40-$50 million to EBITDA. Given the expectations for a border surge once Title 42 is lifted, we do not think this is a stretch….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Cypress Development (CYDVF) – Drill Results Highlight Opportunity for an Extended Shallow Pit Design

Friday, August 05, 2022

Cypress Development (CYDVF)
Drill Results Highlight Opportunity for an Extended Shallow Pit Design

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Sonic drill program. Cypress Development reported results from its sonic drill program intended to obtain material for metallurgical testing at the company’s lithium extraction pilot plant and to supplement the project’s resource model for the feasibility study that is expected to be completed by year-end. Eight holes were drilled representing a total of 580 meters with depths ranging from 61 to 76 meters. Four holes were drilled in the central part of the Clayton Valley property near the planned location of a starter-pit, while four holes were drilled in the northeast portion of the project on and near a parcel of property acquired in May from Enertopia Corporation.

Results validated the company’s resource model. The assay results were in line with lithium grades predicted at all eight locations by the company’s resource block model. The compiled average lithium grade from all eight holes were 1,080 parts per million lithium compared to 1,060 parts per million predicted by the company’s current resource model for all eight locations….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Genco Shipping (GNK) – Results rise even as the company takes steps to position itself for the future

Friday, August 05, 2022

Genco Shipping (GNK)
Results rise even as the company takes steps to position itself for the future

Genco Shipping & Trading Limited, incorporated on September 27, 2004, transports iron ore, coal, grain, steel products and other drybulk cargoes along shipping routes through the ownership and operation of drybulk carrier vessels. The Company is engaged in the ocean transportation of drybulk cargoes around the world through the ownership and operation of drybulk carrier vessels. As of December 31, 2016, its fleet consisted of 61 drybulk carriers, including 13 Capesize, six Panamax, four Ultramax, 21 Supramax, two Handymax and 15 Handysize drybulk carriers, with an aggregate carrying capacity of approximately 4,735,000 deadweight tons (dwt). Of the vessels in its fleet, 15 are on spot market-related time charters, and 27 are on fixed-rate time charter contracts. As of December 31, 2016, additionally, 19 of the vessels in its fleet were operating in vessel pools.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Genco Shipping reported 2022-2Q results above our estimates but below consensus estimates. Net revenues were $100.9 million vs. $76.0 million last year, above our $97.1 million estimate but below the consensus estimate of $109.1 million. Adjusted EBITDA for the quarter was $64.2 million, up 28% but below our estimate of $67.1 million and the consensus estimate of $67.4 million. Net income was $47.5 million ($1.10 per share) vs. our estimate of $43.6 million ($1.01 per share) and the consensus estimate of $50.5 million ($1.17 per share).

Why were costs up? Daily vessel operating expenses were $7.358/day in the second quarter versus $5,151/day last year. The company is switching technical management companies. The changeover required higher repair and maintenance costs and an increase in the purchase of stores and spare parts. In addition, the company completed an entire crew changeover as ships came into dock. The good news is that the changeover is largely complete and vessel operating expenses are expected to drop to $4,950 in the upcoming quarter….

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Lee Enterprises (LEE) – Its Three Pillar Strategy Is Working

Friday, August 05, 2022

Lee Enterprises (LEE)
Its Three Pillar Strategy Is Working

Lee Enterprises, Incorporated provides local news, information, and advertising primarily in midsize markets in the United States. It publishes 49 daily newspapers, as well as offers 300 weekly newspapers and specialty publications in 23 states. The company also provides online advertising and services; and online infrastructure and online publishing services for approximately 1,500 daily and weekly newspapers and shoppers. In addition, it offers commercial printing services. The company has a strategic alliance with Yahoo!, Inc. to provide its classified employment advertising customer base the opportunity to post job listings and other employment products on Yahoo!s HotJobs national platform. Lee Enterprises, Incorporated was founded in 1890 and is based in Davenport, Iowa.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Strong fiscal Q3. Q3 revenue was $195 million, 1.7% above our forecast of $191.7 million. Adj. EBITDA of $23 million was in line with our forecast. The revenue beat was driven by strong 27% growth of Digital revenue, which now accounts for 32% of total revenues.

Digital ahead of schedule. Digital revenue growth was driven by Digital-only subscription revenue, up 50%, and Digital Ad & Marketing Services revenue, up nearly 27%. Notably, Digital only subscribers were up 49% to 501,000, achieving the year-end subscriber goal of 495,000 a full quarter early. We believe the most recent quarter demonstrates an industry-leading Digital transformation strategy, which capitalizes on Lee’s local market focus.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Salem Media Group (SALM) – 2000 Mules Boost Quarterly Results

Friday, August 05, 2022

Salem Media Group (SALM)
2000 Mules Boost Quarterly Results

Salem Media Group is America’s leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overachieves Q2 estimates. While total company revenues of $68.7 million were in line with our $68.8 million estimate, adj. EBITDA overachieved estimates, $11.7 million versus our $7.3 million estimate. Adj. EBITDA, which increased 33%,  benefited from a $3.3 million revenue share from the successful movie launch of 2000 Mules. 

Political advertising off the charts. The company generated $1.5 million in Political advertising in the latest quarter, far outpacing its highest Political year in 2020. …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Seanergy Maritime (SHIP) – Results in line with recent revisions

Friday, August 05, 2022

Seanergy Maritime (SHIP)
Results in line with recent revisions

Seanergy Maritime Holdings Corp. is the only pure-play Capesize ship-owner publicly listed in the US. Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels. The Company’s operating fleet consists of 17 Capesize vessels with an average age of approximately 12 years and aggregate cargo carrying capacity of approximately 3,011,083 dwt. The Company is incorporated in the Marshall Islands and has executive offices in Glyfada, Greece. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP” and its Class B warrants under “SHIPZ”.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Seanergy reported 2022-2Q results in line with expectations. SHIP reported net revenues of $32.8 million up 18% over last year and slightly above our estimate of $31.1 million. EBITDA of $16.1 million met our $16.2 million estimate and reported net income of $5.9 million ($0.03 per share) was slightly above our $5.5 million ($0.03 per share) estimate. We had fine-tuned our projections last month after a conversation with management.

TCE rates were the main cause for higher year-over-year result although coming in below early guidance. Average Time Charter Equivalent rates were $23,251 for the quarter in line with our $23,000 estimate. Management had forecast a 2Q TCE rate of $24,569 at the end of the first quarter. Shipping rates remain above historical levels but have fallen as the quarter progressed and concerns of a weakening global economy emerged. Still, the overall outlook remains positive as the iron ore and coal trades are active and China begins to reopen….

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – Kratos Reports Second Quarter 2022 Financial Results



Kratos Reports Second Quarter 2022 Financial Results

Research, News, and Market Data on Kratos Defense & Security Solutions

SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today reported its second quarter 2022 financial results. For the second quarter of 2022, Kratos reported Revenues of $224.2 million, Operating Loss of $1.9 million, Net Loss of $4.7 million, Adjusted EBITDA of $17.7 million and a book to bill ratio of 1.2 to 1.0.   Included in Net Loss is a $5.5 million litigation settlement related charge resulting from the resolution of a dispute with an international customer in our Unmanned Systems segment, which contractual arrangement was entered into in March 2011, prior to Kratos’ acquisition of CEi (Composite Engineering Inc.).

Second quarter 2022 Operating Loss includes non-cash stock compensation expense of $6.3 million, and Company-funded Research and Development expense of $9.2 million, reflecting significant ongoing development efforts being made, including in our Space and   Satellite business to develop our virtual, software-based OpenSpace ground station solution.

Kratos reported a second quarter 2022 GAAP loss per share of $0.04, which includes the $5.5 million litigation settlement related charge noted above, compared to Net Income of $1.1 million and GAAP EPS income of $0.01 for the second quarter of 2021. Adjusted EPS was $0.07 for the second quarter of 2022, compared to $0.06 for the second quarter of 2021. Kratos has approximately $235 million of net operating loss carryforwards, which are expected to substantially shield the Company from paying future cash income taxes.   

Second quarter 2022 Revenues of $224.2 million, which increased $19.1 million, or 9.3 percent, from second quarter 2021 Revenues of $205.1 million, were adversely impacted by continuing and increased supply chain disruptions and increased material costs, COVID-related employee absenteeism and increased challenges and costs associated with hiring, obtaining and retaining qualified employees, which resulted in approximately $14.5 million of second quarter 2022 revenues being deferred into future periods, with approximately $2.9 million of associated operating income, including increased inflationary costs.    Second quarter 2022 revenues include an aggregate contribution of $21.5 million from the recent acquisitions of Cosmic Advanced Engineered Solutions, Inc. (Cosmic AES), CTT, Inc., (CTT), and the Engineering Division of Southern Research (SRE), offset by reductions in our Training Solutions business of $8.6 million as compared to the second quarter 2021 revenues, including the previously reported loss of an international training services contract which accounted for approximately $4.5 million of the reduction as well as the completion of certain large training system programs. On a proforma basis, excluding the impact of the Training Solutions business, revenues grew organically 3.2% in the second quarter of 2022 as compared to the second quarter of 2021.

Second quarter 2022 Cash Flow Used in Operations was $21.6 million, with the use including increases in receivables of $27.1 million primarily related to future milestone and other contractual payments and an increase of inventory balances of $10.5 million, primarily in our Unmanned Systems, Microwave Products and C5ISR businesses in anticipation of expected significant ramps in production in the second half of the year and to increase stock inventory levels and advance buys in larger lot sizes to gain pricing benefits where possible, to mitigate the impact of supply chain disruptions and price increases. Free Cash Flow Used in Operations was $32.7 million, after funding $11.1 million of capital expenditures, including in our high growth Unmanned Systems, Space, Satellite and Cyber and Turbine Technologies business areas.

For the second quarter of 2022, Kratos’ Unmanned Systems Segment (KUS) generated Revenues of $56.4 million, as compared to $60.3 million in the second quarter of 2021. KUS Operating Loss was $5.0 million in the second quarter of 2022, which included the $5.5 million litigation settlement related charge discussed above. Excluding the impact of the litigation settlement related charge, Operating Income was $0.5 million, compared to $4.1 million in the second quarter of 2021, reflecting a less favorable mix of revenues, including an increase in development programs which typically generate lower margins, an increase in SG&A costs of approximately $0.9 million resulting primarily from increased headcount, an increase of R&D expenses of approximately $1.3 million and increases in supply chain and employee related costs.

Excluding the litigation settlement charge, KUS Adjusted EBITDA for the second quarter of 2022 was $2.9 million, compared to second quarter 2021 Adjusted EBITDA of $6.9 million, reflecting increases in certain development programs which typically generate lower margins and increases in SG&A, R&D, supply chain related and employee costs.
        

KUS’s book-to-bill ratio for the second quarter of 2022 was 0.5 to 1.0 and 1.1 to 1.0 for the last twelve months ended June 26, 2022, with bookings of $242.6 million for the twelve months ended June 26, 2022.   Total backlog for KUS at the end of the second quarter of 2022 was $203.3 million compared to $230.5 million at the end of the first quarter of 2022.

For the second quarter of 2022, Kratos’ Government Solutions Segment (KGS) reported Revenues of $167.8 million, compared to Revenues of $144.8 million in the second quarter of 2021. The increased revenues include the aggregate contribution of approximately $21.5 million from the recently acquired Cosmic AES, CTT and SRE, offset by a reduction of $8.6 million in our Training Solutions business, including the loss of an international training contract, continued and increased supply chain, COVID and employee sourcing and retention disruptions, which resulted in second quarter 2022 KGS revenues of approximately $13.9 million being deferred into future periods.    On a proforma basis, excluding the Training Solutions business, KGS revenues grew organically 7.7 percent or $10.2 million, from $132.3 million in the second quarter of 2021 to $142.5 million in the second quarter of 2022.

KGS reported operating income of $9.5 million in the second quarter of 2022, compared to $5.9 million in the second quarter of 2021, primarily reflecting a more favorable revenue mix, offset partially by increased costs related to the supply chain and employee base.  

Kratos’ Space, Satellite and Cyber business generated Revenues of $88.5 million in the second quarter of 2022, compared to $67.5 million in the second quarter of 2021. Excluding revenues generated of $15.0 million from the recent Cosmic AES acquisition, revenues for our Space, Satellite and Cyber business grew organically 8.9 percent in the second quarter of 2022.

Second quarter 2022 KGS Adjusted EBITDA was $14.8 million, compared to second quarter 2021 KGS Adjusted EBITDA of $10.7 million, reflecting a more favorable mix of revenues, including in our Space, Satellite and Cyber and Turbine Technologies businesses.

For the second quarter of 2022, KGS reported a book-to-bill ratio of 1.4 to 1.0, with a book to bill ratio of 1.2 to 1.0 for the twelve months ended June 26, 2022, and bookings of $713.9 million for the twelve months ended June 26, 2022.   Included in KGS is Kratos’ Space, Satellite and Cyber business, which reported a book to bill ratio of 1.7 to 1.0 for the second quarter of 2022, and a book to bill ratio of 1.2 to 1.0 for the twelve months ended June 26, 2022. Bookings for the Space, Satellite and Cyber business for the last twelve months ended June 26, 2022, were $371.1 million. KGS’s total backlog at the end of the second quarter of 2022 was $846.9 million, as compared to $751.6 million at the end of the first quarter of 2022.

For the second quarter of 2022, Kratos reported consolidated bookings of $261.0 million and a book-to-bill ratio of 1.2 to 1.0, with consolidated bookings of $956.5 million and a book-to-bill ratio of 1.1 to 1.0 for the last twelve months ended June 26, 2022. Backlog on June 26, 2022 was $1.05 billion, as compared to $982.1 million at March 27, 2022, and Kratos’ bid and proposal pipeline was $9.9 billion at June 26, 2022, as compared to $9.4 billion at March 27, 2022.   Backlog at June 26, 2022 was comprised of funded backlog of $713.6 million and unfunded backlog of $336.6 million.

Eric DeMarco, Kratos’ President and CEO, said, “Kratos’ second quarter execution was solid in a challenging environment, including revenues of $224 million, Adjusted EBITDA of $17.7 million, a 1.2 to 1.0 book to bill ratio and a current opportunity pipeline of over $9 billion. We have now received each of the three important, large new satellite related program awards we discussed in our Q1 2022 report, including contracts with Blue Halo and Intelsat, which we believe position Kratos for future organic growth and increased margins beginning in the second half of this year. We believe these awards are representative of the increasing customer acceptance of Kratos’ first to market, internally funded and developed, software-based OpenSpace virtualized family of products and we are now in pursuit of several additional, large, new satellite program opportunities.”

Mr. DeMarco, continued, “Since our last report to you, the Air Force announced to Congress that the Skyborg Vanguard program, which includes Kratos’ Valkyrie, is now planned to be a Program of Record in 2023 and transition to acquisition. Additionally, Kratos’ tactical drone business continues to progress, including recent successful flights at the Burns Flat, Oklahoma range and other locations, and we are expecting to receive certain new tactical drone related contract awards in the second half of this year, including as related to Valkyrie.   Also importantly, the Air Force recently announced that the Golden Horde Vanguard Program, which Kratos is also supporting, is now also slated to become a Program of Record in 2023, which includes networked, collaborative and autonomous munitions and drones.”     

Mr. DeMarco concluded, “Based on important recent events and communications, we continue to believe that the global security environment and requirement for affordable, reusable, disposable and attritable high performance jet drones has never been stronger and is increasing. We view Kratos’ family of Made in America, demonstrated low-cost, runway independent, Collaborative Combat Aircraft, that have been flying with manned fighter aircraft since 2015, and are not concepts, power points or video presentations that are years away from reality, along with active Kratos serial production lines that can provide Affordable Mass now, are important differentiators for our Country, our customers and our Company.”

Financial Guidance
Our third quarter and Fiscal Year 2022 financial guidance we are providing today includes our current forecasted business mix, and our assumptions related to the expected continuing impact of: employee absenteeism, employee sourcing, hiring and retention; manufacturing, production and supply chain disruptions; parts shortages and related significant cost and price increases, including for employees, materials and components; travel restrictions and other COVID-19 related items that have and continue to impact the industry and Kratos.   The growth expected in the fourth quarter of 2022 is largely driven by the forecasted execution and delivery schedules of 5 new programs, 4 of which have already been awarded: the three satellite program awards, GBSD and an expected Valkyrie award from a new customer.        

The revised full Fiscal Year 2022 financial guidance reflects the expected revenue growth, including the impact of the recent SRE acquisition, as well as expected organic revenue growth driven by our recent bookings and backlog. Since our contract mix is predominantly firm fixed price, we are contractually obligated to absorb the impact of significant inflationary factors until we are able to include our revised costs in new contracts or the exercise of contractual options, which is reflected in our revised Fiscal Year 2022 Adjusted EBITDA guidance.

$M

Q322

FY22

Revenues

$220 – $230

$890 – $930

R&D

$9 – $10

$35 – $38

Operating Income

$0 – $3

$13 – $18

Depreciation

$7

$24 – $25

Amortization

$3

$8 – $9

Stock Based Compensation

$6 – $7

$25 – $26

Adjusted EBITDA

$16 – $20

$80 – $85

Operating Cash Flow

 

$15 – $25

Capital Expenditures

 

$45 – $55

Free Cash Flow Use

 

($30 – $40)

 

Throughout the second quarter of 2022, we continued to experience the effects of COVID–19, including on our employees, consultants, vendors, suppliers, customers, etc. We have assumed that these COVID–19 related impacts to our business, which significantly impacted our fiscal first and second quarters of 2022 and continue to impact our third quarter, will continue at least through the end of calendar 2022. Our previous assumption was that COVID-19 related impacts would begin to subside beginning in the third fiscal quarter and continue to improve throughout the second half of our fiscal year 2022.

We currently estimate that COVID, supply chain, work force and inflation related issues, including the availability and increased costs of certain raw materials and related components and materials, a lack of capacity at mills supporting Kratos’ hardware programs, the availability and significant increased costs to obtain and the ability to retain an experienced skilled workforce will continue to impact our financial performance throughout 2022. We expect these issues to impact our third quarter 2022 Revenues by approximately $10 to $14 million and Adjusted EBITDA by approximately $3 to $5 million, respectively. We also currently estimate these issues to impact our full fiscal year 2022 Revenues by approximately $22 to $26 million and Adjusted EBITDA by approximately $10 to $13 million, respectively. We will provide future updates as appropriate.  

The forecasted financial trajectory in the second half of 2022 reflects the expected mix of revenues, including the expected timing of software product deliveries in our Space, Satellite and Cyber business, based upon the forecasted order flow and roll out of our new OpenSpace solution, and contract awards we have recently received or that we have been informed we will receive, with deliveries expected to occur predominantly in the fourth quarter of 2022 based upon current program execution plans.  

Forecasted third quarter 2022 and fiscal year 2022 Operating Income and Adjusted EBITDA also reflect the expected mix of development-type contracts and expected investments, including in our Space, Satellite and Cyber, Unmanned Systems, C5ISR, Turbine Technologies and Rocket System businesses, where we have received, have been informed that we will receive, or are pursuing or expect to receive several new contract awards.   Kratos’ fiscal year 2022 forecasted Revenues also include the final projected impact of the 2021 loss of a large international training contract, which contributed approximately $13.0 million to the Company’s fiscal year 2021 first and second quarter Revenues and include the estimated contribution from the recently closed CTT, Cosmic AES and SRE acquisitions.  

Management will discuss the Company’s second quarter 2022 financial results, as well as its third quarter and full year 2022 guidance on a conference call beginning at 2:00 p.m. Pacific (5:00 p.m. Eastern) today. The call will be available at www.kratosdefense.com. Participants may register for the call at 
https://register.vevent.com/register/BId7480930af214120a135751b6240fd74. While not required, it is recommended you join 10 minutes prior to the event start. Instructions are provided to ensure the necessary audio applications are downloaded and installed. Users can obtain these programs at no charge. For those who cannot access the live broadcast, a replay will be available on Kratos’ website.

About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms, and systems for United States National Security related customers, allies, and commercial enterprises.  Kratos is changing the way breakthrough technologies for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes.  At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.kratosdefense.com.

Notice Regarding Forward-Looking Statements
This news release contains certain forward-looking statements that involve risks and uncertainties, including, without limitation, express or implied statements concerning the Company’s expectations regarding its future financial performance, including the Company’s expectations for its third quarter and full year 2022 revenues, R&D, operating income, depreciation, amortization, stock based compensation expense, and Adjusted EBITDA, and full year 2022 operating cash flow, capital expenditures and other investments, and free cash flow use, the Company’s future growth trajectory and ability to achieve improved revenue mix and profit in certain of its business segments and the expected timing of such improved revenue mix and profit, the Company’s expectation of ramp on projects and that investments in its business will result in an increase in the Company’s market share and total addressable market and position the Company for significant future organic growth, profitability, cash flow and an increase in shareholder value, the Company’s bid and proposal pipeline, demand for its products and services, including the Company’s alignment with today’s National Security requirements, ability to successfully compete in the tactical unmanned aerial system area and expected new customer awards, including the magnitude and timing of funding and the future opportunity associated with such awards, and expected contract awards related to the Company’s Skyborg Vanguard program, Golden Horde Vanguard program and other new tactical unmanned programs, performance of key contracts and programs, including the timing of production and demonstration related to certain of the Company’s contracts and product offerings, the impact of the Company’s restructuring efforts and cost reduction measures, including its ability to improve profitability and cash flow in certain business units as a result of these actions and to achieve financial leverage on fixed administrative costs, benefits to be realized from the Company’s net operating loss carry forwards, the availability and timing of government funding for the Company’s offerings, including the strength of the future funding environment, the short-term delays that may occur as a result of Continuing Resolutions or delays in DoD budget approvals, timing of LRIP and full rate production related to the Company’s unmanned aerial target system offerings, as well as the level of recurring revenues expected to be generated by these programs once they achieve full rate production, market and industry developments, and the current estimated impact of COVID-19 and employee absenteeism, supply chain disruptions, availability of an experienced skilled workforce, inflation and increased costs, and delays on our financial projections, industry, business and operations, including projected growth. Such statements are only predictions, and the Company’s actual results may differ materially from the results expressed or implied by these statements. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Factors that may cause the Company’s results to differ include, but are not limited to: risks to our business and financial results related to the reductions and other spending constraints imposed on the U.S. Government and our other customers, including as a result of sequestration and extended continuing resolutions, the Federal budget deficit and Federal government shut-downs; risks of adverse regulatory action or litigation; risks associated with debt leverage and cost savings and cash flow improvements expected as a result of the refinancing of our Senior Notes; risks that our cost-cutting initiatives will not provide the anticipated benefits; risks that changes, cutbacks or delays in spending by the U.S. DoD may occur, which could cause delays or cancellations of key government contracts; risks of delays to or the cancellation of our projects as a result of protest actions submitted by our competitors; risks that changes may occur in Federal government (or other applicable) procurement laws, regulations, policies and budgets; risks of the availability of government funding for the Company’s products and services due to performance, cost growth, or other factors, changes in government and customer priorities and requirements (including cost-cutting initiatives, the potential deferral of awards, terminations or reduction of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional committee recommendations or automatic sequestration under the Budget Control Act of 2011, as amended); risks that the UAS and UGS markets do not experience significant growth; risks that products we have developed or will develop will become programs of record; risks that we cannot expand our customer base or that our products do not achieve broad acceptance which could impact our ability to achieve our anticipated level of growth; risks of increases in the Federal government initiatives related to in-sourcing; risks related to security breaches, including cyber security attacks and threats or other significant disruptions of our information systems, facilities and infrastructures; risks related to our compliance with applicable contracting and procurement laws, regulations and standards; risks related to the new DoD Cybersecurity Maturity Model Certification (CMMC); risks related to contract performance; risks related to failure of our products or services; risks associated with our subcontractors’ or suppliers’ failure to perform their contractual obligations, including the appearance of counterfeit or corrupt parts in our products; changes in the competitive environment (including as a result of bid protests); failure to successfully integrate acquired operations and competition in the marketplace, which could reduce revenues and profit margins; risks that potential future goodwill impairments will adversely affect our operating results; risks that anticipated tax benefits will not be realized in accordance with our expectations; risks that a change in ownership of our stock could cause further limitation to the future utilization of our net operating losses; risks that we may be required to record valuation allowances on our net operating losses which could adversely impact our profitability and financial condition; risks that the current economic environment will adversely impact our business; currently unforeseen risks associated with COVID-19 and risks related to natural disasters or severe weather. These and other risk factors are more fully discussed in the Company’s Annual Report on Form 10-K for the period ended December 26, 2021, and in our other filings made with the Securities and Exchange Commission.

Note Regarding Use of Non-GAAP Financial Measures and Other
Performance Metrics

This news release contains non-GAAP financial measures, including Adjusted earnings per share (computed using income from continuing operations before income taxes, excluding income (loss) from discontinued operations, excluding income (loss) attributable to non-controlling interest, excluding depreciation, amortization of intangible assets, amortization of capitalized contract and development costs, stock-based compensation expense, acquisition and restructuring related items and other, which includes, but is not limited to, legal related items and foreign transaction gains and losses, less the estimated impact to income taxes) and including Adjusted EBITDA (which includes net income (loss) attributable to noncontrolling interest and excludes, among other things, losses and gains from discontinued operations, acquisition and restructuring related items, stock compensation expense, foreign transaction gains and losses, and the associated margin rates). Additional non-GAAP financial measures include Free Cash Flow from Operations computed as Cash Flow from Operations less Capital Expenditures and Adjusted EBITDA related to our KUS and KGS businesses. Kratos believes this information is useful to investors because it provides a basis for measuring the Company’s available capital resources, the actual and forecasted operating performance of the Company’s business and the Company’s cash flow, excluding non-recurring items and non-cash items that would normally be included in the most directly comparable measures calculated and presented in accordance with GAAP. The Company’s management uses these non-GAAP financial measures, along with the most directly comparable GAAP financial measures, in evaluating the Company’s actual and forecasted operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and investors should carefully evaluate the Company’s financial results calculated in accordance with GAAP and reconciliations to those financial results. In addition, non-GAAP financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies. As appropriate, the most directly comparable GAAP financial measures and information reconciling these non-GAAP financial measures to the Company’s financial results prepared in accordance with GAAP are included in this news release.

Another Performance Metric the Company believes is a key performance indicator in our industry is our Book to Bill Ratio as it provides investors with a measure of the amount of bookings or contract awards as compared to the amount of revenues that have been recorded during the period and provides an indicator of how much of the Company’s backlog is being burned or utilized in a certain period. The Book to Bill Ratio is computed as the number of bookings or contract awards in the period divided by the revenues recorded for the same period. The Company believes that the rolling or last twelve months’ Book to Bill Ratio is meaningful since the timing of quarter-to-quarter bookings can vary.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687

investor@kratosdefense.com 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Statements of Operations

 

 

(in millions, except per share
data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service revenues

 

$

78.8

 

 

$

58.0

 

 

$

146.7

 

 

$

115.3

 

 

 

Product sales

 

 

145.4

 

 

 

147.1

 

 

 

273.7

 

 

 

284.0

 

 

 

Total revenues

 

 

224.2

 

 

 

205.1

 

 

 

420.4

 

 

 

399.3

 

 

 

Cost of service revenues

 

 

56.2

 

 

 

41.3

 

 

 

106.1

 

 

 

83.8

 

 

 

Cost of product sales

 

 

110.2

 

 

 

111.8

 

 

 

204.6

 

 

 

212.5

 

 

 

Total costs

 

 

166.4

 

 

 

153.1

 

 

 

310.7

 

 

 

296.3

 

 

 

Gross profit – service revenues

 

 

22.6

 

 

 

16.7

 

 

 

40.6

 

 

 

31.5

 

 

 

Gross profit – product sales

 

 

35.2

 

 

 

35.3

 

 

 

69.1

 

 

 

71.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Total gross profit

 

 

57.8

 

 

 

52.0

 

 

 

109.7

 

 

 

103.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

41.6

 

 

 

35.6

 

 

 

81.9

 

 

 

70.9

 

 

 

Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

Research and development expenses

 

 

9.2

 

 

 

10.2

 

 

 

18.4

 

 

 

18.2

 

 

 

Depreciation

 

 

1.3

 

 

 

1.4

 

 

 

2.6

 

 

 

2.6

 

 

 

Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

     Operating income (loss)

 

 

(1.9

)

 

 

3.3

 

 

 

(3.1

)

 

 

8.2

 

 

 

Interest expense, net

 

 

(2.9

)

 

 

(5.7

)

 

 

(8.8

)

 

 

(11.6

)

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

(13.0

)

 

 

 

 

 

Other income, net

 

 

 

 

 

 

 

 

0.1

 

 

 

0.2

 

 

 

Loss from continuing operations before income taxes

 

 

(4.8

)

 

 

(2.4

)

 

 

(24.8

)

 

 

(3.2

)

 

 

Provision (benefit) for income taxes from continuing operations

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Income (loss) from continuing operations

 

 

(5.3

)

 

 

1.2

 

 

 

(21.0

)

 

 

3.1

 

 

 

Income (loss) from discontinued operations, net of income taxes

 

 

0.9

 

 

 

(0.3

)

 

 

0.7

 

 

 

(0.3

)

 

 

     Net income (loss)

 

 

(4.4

)

 

 

0.9

 

 

 

(20.3

)

 

 

2.8

 

 

 

     Less: Net income (loss) attributable to noncontrolling interest

 

 

0.3

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

     Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per common share attributable to Kratos:

 

 

 

 

 

 

 

 

 

 

     Income (loss) from continuing operations

 

$

(0.04

)

 

$

0.01

 

 

$

(0.17

)

 

$

0.02

 

 

 

     Income (loss) from discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 

 

 

 

     Net income (loss)

 

 

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per common share attributable to Kratos:

 

 

 

 

 

 

 

 

 

 

     Income (loss) from continuing operations

 

$

(0.04

)

 

$

0.01

 

 

$

(0.17

)

 

$

0.02

 

 

 

     Income (loss) from discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 

 

 

 

     Net income (loss)

 

$

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

     Basic weighted average common shares outstanding

 

 

126.4

 

 

 

124.7

 

 

 

126.2

 

 

 

124.4

 

 

 

     Diluted weighted average common shares outstanding

 

 

126.4

 

 

 

127.7

 

 

 

126.2

 

 

 

127.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA (1)

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Reconciliation of GAAP to Non-GAAP Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: (1) Adjusted EBITDA is a non-GAAP measure defined as GAAP net income (loss) attributable to Kratos adjusted for net income (loss)

 

 

 

 

attributable to noncontrolling interest, income (loss) from discontinued operations, net interest expense, provision (benefit) for income taxes, depreciation and

 

 

amortization expense of intangible assets, amortization of capitalized contract and development costs, stock-based compensation,

 

 

 

 

 

 

acquisition and restructuring related items and other, and foreign transaction gain (loss).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA as calculated by us may be calculated differently than Adjusted EBITDA for other companies. We have provided

 

 

 

 

 

 

Adjusted EBITDA because we believe it is a commonly used measure of financial performance in comparable companies and is provided to

 

 

 

 

help investors evaluate companies on a consistent basis, as well as to enhance understanding of our operating results. Adjusted EBITDA

 

 

 

 

should not be construed as either an alternative to net income or as an indicator of our operating performance or an alternative to cash flows

 

 

 

 

as a measure of liquidity. The adjustments to calculate this non-GAAP financial measure and the basis for such adjustments are outlined below.

 

 

 

 

Please refer to the following table below that reconciles GAAP net income (loss) to Adjusted EBITDA.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The adjustments to calculate this non-GAAP financial measure, and the basis for such adjustments, are outlined below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income and interest expense, net. The Company receives interest income on investments and incurs interest expense on loans, capital leases and

 

 

other financing arrangements, including the amortization of issue discounts and deferred financing costs. These amounts may vary from period to period

 

 

due to changes in cash and debt balances.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes. The Company’s tax expense can fluctuate materially from period to period due to tax adjustments that may not be directly related to

 

 

 

 

underlying operating performance or to the current period of operations and may not necessarily reflect the impact of utilization of our NOLs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation. The Company incurs depreciation expense (recorded in cost of revenues and in operating expenses) related to capital assets purchased,

 

 

 

 

leased or constructed to support the ongoing operations of the business. The assets are recorded at cost or fair value and are depreciated over the estimated

 

 

useful lives of individual assets.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets. The Company incurs amortization of intangible expense related to acquisitions it has made. These intangible assets are

 

 

valued at the time of acquisition and are amortized over the estimated useful lives.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of capitalized contract and development
costs. 
The Company incurs amortization of previously capitalized software development and non-

 

 

 

recurring engineering costs related to certain targets in its Unmanned Systems and ballistic missile target businesses as these units are sold.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense. The Company incurs expense related to stock-based compensation included in its GAAP presentation of selling,

 

 

 

 

general and administrative expense. Although stock-based compensation is an expense of the Company and viewed as a form of compensation, these

 

 

 

 

expenses vary in amount from period to period, and are affected by market forces that are difficult to predict and are not within the control of management,

 

 

such as the market price and volatility of the Company’s shares, risk-free interest rates and the expected term and forfeiture rates of the awards.

 

 

 

 

Management believes that exclusion of these expenses allows comparison of operating results to those of other companies that disclose non-GAAP

 

 

 

 

financial measures that exclude stock-based compensation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign transaction (gain) loss. The Company incurs transaction gains and losses related to transactions with foreign customers in currencies other than

 

 

 

the U.S. dollar. In addition, certain intercompany transactions can give rise to realized and unrealized foreign currency gains and losses.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition and transaction related items. The Company incurs transaction related costs, such as legal and accounting fees and other expenses, related to

 

 

acquisitions and divestiture activities. Management believes these items are outside the normal operations of the Company’s business and are not

 

 

 

 

indicative of ongoing operating results.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring costs. The Company incurs restructuring costs for cost reduction actions which include employee termination costs,

 

 

 

 

 

 

facility shut-down related costs and remaining lease commitment costs for excess or exited facilities. Management believes that these costs are not

 

 

 

 

indicative of ongoing operating results as they are either non-recurring and/or not expected when full capacity and volumes are achieved.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Legal related items. The Company incurs costs related to pending legal settlements and other legal related matters. Management believes

 

 

 

 

these items are outside the normal operations of the Company’s business and are not indicative of ongoing operating results.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA is a non-GAAP financial measure and should not be considered in isolation or as a substitute for financial information provided in

 

 

 

 

accordance with GAAP. This non-GAAP financial measure may not be computed in the same manner as similarly titled measures used by other

 

 

 

 

companies. The Company expects to continue to incur expenses similar to the Adjusted EBITDA financial adjustments described above, and investors

 

 

 

 

should not infer from the Company’s presentation of this non-GAAP financial measure that these costs are unusual, infrequent, or non-recurring.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net income (loss) attributable to Kratos to Adjusted EBITDA is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

Loss (income) from discontinued operations, net of income taxes

 

 

(0.9

)

 

 

0.3

 

 

 

(0.7

)

 

 

0.3

 

 

 

Interest expense, net

 

 

2.9

 

 

 

5.7

 

 

 

8.8

 

 

 

11.6

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Provision (benefit) for income taxes from continuing operations

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Depreciation (including cost of service revenues and product sales)

 

 

5.3

 

 

 

5.8

 

 

 

10.6

 

 

 

10.7

 

 

 

Stock-based compensation

 

 

6.3

 

 

 

6.6

 

 

 

13.3

 

 

 

12.8

 

 

 

Foreign transaction loss

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.2

 

 

 

Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

Plus: Net income (loss) attributable to noncontrolling interest

 

 

0.3

 

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of acquisition and restructuring related items and other included in Adjusted EBITDA:

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Acquisition and transaction related items

 

$

0.1

 

 

$

0.1

 

 

$

0.4

 

 

$

0.3

 

 

 

Restructuring costs

 

 

0.2

 

 

 

0.2

 

 

 

0.3

 

 

 

0.2

 

 

 

Legal related items

 

 

5.7

 

 

 

 

 

 

5.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

6.0

 

 

$

0.3

 

 

$

6.6

 

 

$

0.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Segment Data

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

Unmanned Systems

 

$

56.4

 

 

$

60.3

 

 

$

109.0

 

 

$

116.2

 

 

 

Kratos Government Solutions

 

 

167.8

 

 

 

144.8

 

 

 

311.4

 

 

 

283.1

 

 

 

Total revenues

 

$

224.2

 

 

$

205.1

 

 

$

420.4

 

 

$

399.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

 

 

 

Unmanned Systems

 

$

(5.0

)

 

$

4.1

 

 

$

(4.5

)

 

$

8.3

 

 

 

Kratos Government Solutions

 

 

9.5

 

 

 

5.9

 

 

 

15.1

 

 

 

13.0

 

 

 

Unallocated corporate expense, net

 

 

(6.4

)

 

 

(6.7

)

 

 

(13.7

)

 

 

(13.1

)

 

 

Total operating income (loss)

 

$

(1.9

)

 

$

3.3

 

 

$

(3.1

)

 

$

8.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: Unallocated corporate expense, net includes costs for certain stock-based compensation programs (including stock-based compensation costs for stock options, employee stock purchase plan and restricted stock units), the effects of items not considered part of management’s evaluation of segment operating performance, and acquisition and restructuring related items, corporate costs not allocated to the segments, legal related items, and other miscellaneous corporate activities.

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Segment Operating Income (Loss) to Adjusted EBITDA is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Unmanned Systems

 

 

 

 

 

 

 

 

 

 

   Operating income (loss)

 

$

(5.0

)

 

$

4.1

 

 

$

(4.5

)

 

$

8.3

 

 

 

   Other income

 

 

 

 

 

 

 

 

0.1

 

 

 

0.1

 

 

 

   Depreciation

 

 

1.7

 

 

 

2.2

 

 

 

3.3

 

 

 

3.8

 

 

 

   Amortization of intangible assets

 

 

0.2

 

 

 

0.3

 

 

 

0.5

 

 

 

0.6

 

 

 

   Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

   Acquisition and restructuring related items and other

 

 

5.7

 

 

 

 

 

 

5.9

 

 

 

 

 

 

      Adjusted EBITDA

 

$

2.9

 

 

$

6.9

 

 

$

5.9

 

 

$

13.3

 

 

 

  % of revenue

 

 

5.1

%

 

 

11.4

%

 

 

5.4

%

 

 

11.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Government Solutions

 

 

 

 

 

 

 

 

 

 

   Operating income

 

$

9.5

 

 

$

5.9

 

 

$

15.1

 

 

$

13.0

 

 

 

   Other income

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.3

 

 

 

   Depreciation

 

 

3.6

 

 

 

3.6

 

 

 

7.3

 

 

 

6.9

 

 

 

   Amortization of intangible assets

 

 

1.4

 

 

 

0.9

 

 

 

2.8

 

 

 

2.0

 

 

 

   Acquisition and restructuring related items and other

 

 

0.2

 

 

 

0.2

 

 

 

0.3

 

 

 

0.2

 

 

 

      Adjusted EBITDA

 

$

14.8

 

 

$

10.7

 

 

$

25.6

 

 

$

22.4

 

 

 

  % of revenue

 

 

8.8

%

 

 

7.4

%

 

 

8.2

%

 

 

7.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

     Total Adjusted EBITDA

 

$

17.7

 

 

$

17.6

 

 

$

31.5

 

 

$

35.7

 

 

 

  % of revenue

 

 

7.9

%

 

 

8.6

%

 

 

7.5

%

 

 

8.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Balance Sheets

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 26,

 

December 26,

 

 

 

 

 

 

 

 

 

2022

 

 

 

2021

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

$

142.4

 

 

$

349.4

 

 

 

Accounts receivable, net

 

 

 

 

 

 

315.0

 

 

 

284.7

 

 

 

Inventoried costs

 

 

 

 

 

 

118.2

 

 

 

91.7

 

 

 

Prepaid expenses

 

 

 

 

 

 

12.2

 

 

 

9.8

 

 

 

Other current assets

 

 

 

 

 

 

36.5

 

 

 

22.5

 

 

 

Total current assets

 

 

 

 

 

 

624.3

 

 

 

758.1

 

 

 

Property, plant and equipment, net

 

 

 

 

 

 

212.2

 

 

 

168.3

 

 

 

Operating lease right-of-use assets

 

 

 

 

 

 

38.1

 

 

 

38.5

 

 

 

Goodwill

 

 

 

 

 

 

551.9

 

 

 

493.9

 

 

 

Intangible assets, net

 

 

 

 

 

 

64.9

 

 

 

43.2

 

 

 

Other assets

 

 

 

 

 

 

91.9

 

 

 

87.5

 

 

 

Total assets

 

 

 

 

 

$

1,583.3

 

 

$

1,589.5

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

 

 

 

$

58.2

 

 

$

50.4

 

 

 

Accrued expenses

 

 

 

 

 

 

36.0

 

 

 

27.2

 

 

 

Accrued compensation

 

 

 

 

 

 

50.1

 

 

 

47.3

 

 

 

Accrued interest

 

 

 

 

 

 

0.3

 

 

 

1.5

 

 

 

Billings in excess of costs and earnings on uncompleted contracts

 

 

 

 

 

 

59.2

 

 

 

58.1

 

 

 

Current portion of operating lease liabilities

 

 

 

 

 

 

10.6

 

 

 

10.1

 

 

 

Other current liabilities

 

 

 

 

 

 

12.5

 

 

 

25.7

 

 

 

Other current liabilities of discontinued operations

 

 

 

 

 

 

0.9

 

 

 

0.8

 

 

 

Total current liabilities

 

 

 

 

 

 

227.8

 

 

 

221.1

 

 

 

Long-term debt

 

 

 

 

 

 

293.8

 

 

 

296.7

 

 

 

Operating lease liabilities, net of current portion

 

 

 

 

 

 

31.5

 

 

 

32.7

 

 

 

Other long-term liabilities

 

 

 

 

 

 

82.9

 

 

 

76.2

 

 

 

Other long-term liabilities of discontinued operations

 

 

 

 

 

 

1.4

 

 

 

2.5

 

 

 

Total liabilities

 

 

 

 

 

 

637.4

 

 

 

629.2

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interest

 

 

 

 

 

 

7.8

 

 

 

15.2

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

 

 

 

 

 

1,593.1

 

 

 

1,578.9

 

 

 

Accumulated other comprehensive loss

 

 

 

 

 

 

 

 

 

0.6

 

 

 

Accumulated deficit

 

 

 

 

 

 

(655.0

)

 

 

(634.4

)

 

 

Total Kratos stockholders’ equity

 

 

 

 

 

 

938.1

 

 

 

945.1

 

 

 

Total liabilities and stockholders’ equity

 

 

 

 

 

$

1,583.3

 

 

$

1,589.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Condensed Consolidated
Statements of Cash Flows

 

 

(in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 26,

 

June 27,

 

 

 

 

 

 

 

 

 

2022

 

 

 

2021

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

$

(20.3

)

 

$

2.8

 

 

 

Less: income (loss) from discontinued operations

 

 

 

 

 

 

0.7

 

 

 

(0.3

)

 

 

Income (loss) from continuing operations

 

 

 

 

 

 

(21.0

)

 

 

3.1

 

 

 

Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

13.9

 

 

 

13.3

 

 

 

Amortization of lease right-of-use assets

 

 

 

 

 

 

5.3

 

 

 

4.5

 

 

 

Deferred income taxes

 

 

 

 

 

 

0.4

 

 

 

(0.9

)

 

 

Stock-based compensation

 

 

 

 

 

 

13.3

 

 

 

12.8

 

 

 

Litigation related charges

 

 

 

 

 

 

5.5

 

 

 

 

 

 

Amortization of deferred financing costs

 

 

 

 

 

 

0.4

 

 

 

0.5

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Provision for (recovery of) doubtful accounts

 

 

 

 

 

 

 

 

 

(0.2

)

 

 

Changes in assets and liabilities, net of acquisitions:

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

 

 

 

 

0.3

 

 

 

15.5

 

 

 

Unbilled receivables

 

 

 

 

 

 

(15.3

)

 

 

(7.9

)

 

 

Inventoried costs

 

 

 

 

 

 

(25.8

)

 

 

(6.8

)

 

 

Prepaid expenses and other assets

 

 

 

 

 

 

(13.2

)

 

 

(2.2

)

 

 

Operating lease liabilities

 

 

 

 

 

 

(5.5

)

 

 

(4.5

)

 

 

Accounts payable

 

 

 

 

 

 

5.6

 

 

 

5.8

 

 

 

Accrued compensation

 

 

 

 

 

 

(1.3

)

 

 

(1.8

)

 

 

Accrued expenses

 

 

 

 

 

 

7.7

 

 

 

(7.5

)

 

 

Accrued interest

 

 

 

 

 

 

(1.1

)

 

 

 

 

 

Billings in excess of costs and earnings on uncompleted contracts

 

 

 

 

 

 

1.3

 

 

 

9.6

 

 

 

Income tax receivable and payable

 

 

 

 

 

 

(6.2

)

 

 

(6.1

)

 

 

Other liabilities

 

 

 

 

 

 

(6.8

)

 

 

(5.2

)

 

 

Net cash provided by (used in) operating activities from continuing operations

 

 

 

 

 

 

(29.5

)

 

 

22.0

 

 

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

Cash paid for acquisitions, net of cash acquired

 

 

 

 

 

 

(131.9

)

 

 

(6.2

)

 

 

Capital expenditures

 

 

 

 

 

 

(21.9

)

 

 

(20.5

)

 

 

 Proceeds from sale of assets

 

 

 

 

 

 

0.1

 

 

 

 

 

 

Net cash used in investing activities from continuing operations

 

 

 

 

 

 

(153.7

)

 

 

(26.7

)

 

 

Financing activities:

 

 

 

 

 

 

 

 

 

 

Proceeds from the issuance of long-term debt

 

 

 

 

 

 

200.0

 

 

 

 

 

 

Repayment of debt

 

 

 

 

 

 

(309.8

)

 

 

 

 

 

Debt issuance costs

 

 

 

 

 

 

(3.2

)

 

 

 

 

 

Credit agreement borrowings

 

 

 

 

 

 

100.0

 

 

 

 

 

 

Payment under finance leases

 

 

 

 

 

 

(0.6

)

 

 

(0.4

)

 

 

Payments of employee taxes withheld from share-based awards

 

 

 

 

 

 

(11.5

)

 

 

(8.5

)

 

 

Proceeds from shares issued under equity plans

 

 

 

 

 

 

2.9

 

 

 

2.5

 

 

 

Net cash used in financing activities from continuing operations

 

 

 

 

 

 

(22.2

)

 

 

(6.4

)

 

 

Net cash flows from continuing operations

 

 

 

 

 

 

(205.4

)

 

 

(11.1

)

 

 

   Net operating cash flows of discontinued operations

 

 

 

 

 

 

(0.4

)

 

 

(0.8

)

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

 

 

 

 

(1.2

)

 

 

(0.3

)

 

 

Net decrease in cash, cash equivalents and restricted cash

 

 

 

 

 

 

(207.0

)

 

 

(12.2

)

 

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

 

 

 

 

349.4

 

 

 

381.5

 

 

 

Cash, cash equivalents and restricted cash at end of period

 

 

 

 

 

$

142.4

 

 

$

369.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kratos Defense & Security
Solutions, Inc.

 

 

Unaudited Non-GAAP Measures

 

 

Computation of Adjusted Earnings
Per Share

 

 

(in millions, except per share
data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted income from continuing operations and adjusted income from continuing operations per diluted common share (Adjusted EPS) are non-GAAP

 

 

 

 

measures for reporting financial performance and exclude the impact of certain items and, therefore, have not been calculated in accordance with GAAP. Management

 

 

believes that exclusion of these items assists in providing a more complete understanding of the Company’s underlying continuing operations results and trends and allows

 

for comparability with our peer company index and industry. The Company uses these measures along with the corresponding GAAP financial measures

 

 

 

to manage the Company’s business and to evaluate its performance compared to prior periods and the marketplace. The Company defines adjusted

 

 

 

 

income from continuing operations before amortization of intangible assets, depreciation, stock-based compensation, foreign transaction gain/loss, and

 

 

 

acquisition and restructuring related items and other. The estimated impact to income taxes includes the impact to the effective tax rate, current tax provision and

 

 

deferred tax provision, and excludes the impact of discrete items, including transaction related expenses and release of valuation allowance, or benefit related to the add-backs.*

 

Adjusted EPS reflects adjusted income on a per share basis using weighted average diluted shares outstanding.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the most directly comparable GAAP financial measures to the non-GAAP financial measures.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 26,

 

June 27,

 

June 26,

 

June 27,

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Net income (loss) attributable to Kratos

 

$

(4.7

)

 

$

1.1

 

 

$

(20.6

)

 

$

3.0

 

 

 

Less: GAAP provision (benefit) for income taxes

 

 

0.5

 

 

 

(3.6

)

 

 

(3.8

)

 

 

(6.3

)

 

 

Less: Net (income) loss attributable to noncontrolling interest

 

 

0.3

 

 

 

(0.2

)

 

 

0.3

 

 

 

(0.2

)

 

 

Less: Income (loss) from discontinued operations, net of income taxes

 

 

(0.9

)

 

 

0.3

 

 

 

(0.7

)

 

 

0.3

 

 

 

Loss from continuing operations before taxes

 

 

(4.8

)

 

 

(2.4

)

$

 

(24.8

)

 

 

(3.2

)

 

 

Add: Amortization of intangible assets

 

 

1.6

 

 

 

1.2

 

 

 

3.3

 

 

 

2.6

 

 

 

Add: Amortization of capitalized contract and development costs

 

 

0.3

 

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

 

 

Add: Depreciation

 

 

5.3

 

 

 

5.8

 

 

 

10.6

 

 

 

10.7

 

 

 

Add: Stock-based compensation

 

 

6.3

 

 

 

6.6

 

 

 

13.3

 

 

 

12.8

 

 

 

Add: Loss on extinguishment of debt

 

 

 

 

 

 

 

 

13.0

 

 

 

 

 

 

Add: Foreign transaction loss

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

 

 

0.2

 

 

 

Add: Acquisition and restructuring related items and other

 

 

6.0

 

 

 

0.3

 

 

 

6.6

 

 

 

0.5

 

 

 

   Non-GAAP Adjusted income from continuing
operations before income taxes

 

 

14.8

 

 

 

11.9

 

 

 

22.7

 

 

 

24.1

 

 

 

Income taxes on Non-GAAP measure Adjusted income from continuing operations*

 

 

5.4

 

 

 

4.3

 

 

 

8.2

 

 

 

8.8

 

 

 

   Non-GAAP Adjusted net income

 

$

9.4

 

 

$

7.6

 

 

$

14.5

 

 

$

15.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

(0.04

)

 

$

0.01

 

 

$

(0.16

)

 

$

0.02

 

 

 

Less: GAAP provision (benefit) for income taxes

 

 

 

 

 

(0.03

)

 

 

(0.03

)

 

 

(0.05

)

 

 

Less: Net income (loss) attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: Loss (income) from discontinued operations, net of income taxes

 

 

 

 

 

 

 

 

(0.01

)

 

 

 

 

 

Add: Amortization of intangible assets

 

 

0.01

 

 

 

0.01

 

 

 

0.03

 

 

 

0.02

 

 

 

Add: Amortization of capitalized contract and development costs

 

 

 

 

 

 

 

 

 

 

 

0.01

 

 

 

Add: Depreciation

 

 

0.04

 

 

 

0.05

 

 

 

0.08

 

 

 

0.08

 

 

 

Add: Stock-based compensation

 

 

0.05

 

 

 

0.05

 

 

 

0.11

 

 

 

0.10

 

 

 

Add: Loss on extinguishment of debt

 

 

 

 

 

 

 

 

0.10

 

 

 

 

 

 

Add: Foreign transaction loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add: Acquisition and restructuring related items and other

 

 

0.05

 

 

 

 

 

 

0.05

 

 

 

0.01

 

 

 

Income taxes on Non-GAAP measure Adjusted income from continuing operations*

 

 

(0.04

)

 

 

(0.03

)

 

 

(0.06

)

 

 

(0.07

)

 

 

Adjusted income from continuing operations per diluted
common share

 

$

0.07

 

 

$

0.06

 

 

$

0.11

 

 

$

0.12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average diluted common shares outstanding

 

 

126.4

 

 

 

127.7

 

 

 

126.2

 

 

 

127.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*The impact to income taxes is calculated by recasting income before income taxes to include the add-backs involved in determining Adjusted income from continuing

 

operations before income taxes and recalculating the income tax provision (benefit), including current and deferred income taxes, using the Adjusted income from continuing

operations before income taxes. The recalculation also adjusts for any discrete tax expense, including transaction related expenses and the release of valuation allowance, or

benefit related to the add-backs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Primary Logo

Source: Kratos Defense & Security Solutions, Inc.

 



Noble on the Road: Great Lakes Dredge & Dock Corporation (GLDD) Investor Day



Noble on the Road Presents: Great Lakes Dredge & Dock Corporation Investor Day

Noble Capital Markets is hosting an investor day with Great Lakes Dredge & Dock for the New York financial community on Tuesday, September 13th. CEO Lasse Petterson and CFO Scott Kornblau will present and answer questions. This is a no cost event for investors to get to know the company and management.

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) is a leading provider of dredging services in the United States specializing in projects that help improve and protect our nation’s infrastructure and coastlines. With a robust portfolio of major dredging projects, the company brings extensive experience and a strong safety record.

Noble senior analyst Joe Gomes follows the company and has an Outperform rating with a $17.05 price target.

To learn more about Great Lakes Dredge & Dock, click here. The research is complimentary to you.

Yes, I want to meet Great Lakes Dredge & Dock

For more information on this, and other upcoming roadshows, contact:

Barbara Cohen
Managing Director, Investor Outreach & Distribution
Noble Capital Markets, Inc. Direct – (212) 863-3225
bcohen@noblecapitalmarkets.com

Noble on the Road: The GEO Group (GEO) Investor Day



Noble on the Road Presents: The GEO Group Investor Day

Noble Capital Markets is hosting an investor day with The GEO Group for the New York and Connecticut financial communities on Wednesday, September 14th. Brian Evans, CFO of The GEO Group, will present and answer questions. This is a no cost event for investors to get to know the company and management.

GEO provides complementary, turnkey solutions for numerous government partners worldwide across a spectrum of diversified correctional and community reentry services. From the development of state-of-the-art facilities and the provision of management services and evidence-based rehabilitation to the post-release reintegration and supervision of individuals in the community, GEO offers fully diversified, cost-effective services that deliver enhanced quality and improved outcomes

Noble senior analyst Joe Gomes follows the company and has an Outperform rating with a $15 price target.

To learn more about The GEO Group, click here. The research is complimentary to you.

Yes, I want to meet The GEO Group

For more information on this, and other upcoming roadshows, contact:

Barbara Cohen
Managing Director, Investor Outreach & Distribution
Noble Capital Markets, Inc. Direct – (212) 863-3225
bcohen@noblecapitalmarkets.com

Noble on the Road: FAT Brands (FAT) Investor Day



Noble on the Road Presents: FAT Brands Investor Day

Noble Capital Markets is hosting an investor day with FAT Brands for the New York financial community on Thursday, September 15th. Andy Wiederhorn, CEO of FAT Brands, will present and answer questions. This is a no cost event for investors to get to know the company and management.

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets and develops fast casual and casual dining restaurants worldwide. The company’s portfolio includes 15 different brands and franchises over 2,300 units worldwide.

Noble senior analyst Joe Gomes follows the company and has an Outperform rating with a $25 price target.

To learn more about FAT Brands, click here. The research is complimentary to you.

Yes, I want to meet FAT Brands

For more information on this, and other upcoming roadshows, contact:

Barbara Cohen
Managing Director, Investor Outreach & Distribution
Noble Capital Markets, Inc. Direct – (212) 863-3225
bcohen@noblecapitalmarkets.com